Falsified Medical Product Alert N°2/2022
DESREM (remdesivir) for Injection 100 mg/vial: falsified product alert
WHO issued this alert on two falsified batches of DESREM remdesivir reported to WHO in February 2022. Labels have multiple spelling errors and wrong font styles and colours, and vials may be smaller than genuine DESREM.1
- Issued
- 9 March 2022
- Issued by
- World Health Organization
- Name stated on packaging
- Packaging bears the DESREM brand of Mylan Laboratories Ltd with genuine batch numbers and falsified expiry dates.
- Genuine manufacturer's statement
- WHO said Mylan Laboratories Ltd confirmed the products are falsified. Its analysis found no remdesivir in the products.
- Countries where detected
- Guatemala, India
Batches named in the alert
Two batches, listed in Table 1 of the alert. WHO said the batch numbers are genuine but the expiry dates are falsified.
Advice as stated
Do not use the listed products. Obtain medicines only from authorised or licensed suppliers and check their authenticity and condition. Report adverse events or suspected falsification to the national regulatory authority or pharmacovigilance centre.
Names printed on falsified products are not evidence that the named company made them. Where WHO or a regulator reports the genuine manufacturer's statement, it is shown.
Sources
- World Health Organization, Medical Product Alert N°2/2022: Falsified DESREM (Remdesivir) (9 March 2022)